×
Extended-Release Bupropion for Patients With Major Depressive Disorder Presenting With Symptoms of Reduced Energy, Pleasure, and Interest: Findings From a Randomized, Double-Blind, Placebo-Controlled Study PDF
$ 40.00
Extended-Release Bupropion for Patients With Major Depressive Disorder Presenting With Symptoms of Reduced Energy, Pleasure, and Interest: Findings From a Randomized, Double-Blind, Placebo-Controlled Study PDF quantity
$ 40.00
×
Clinical Predictors of Response to Clozapine Treatment in Ambulatory Patients With Schizophrenia PDF
$ 40.00
Clinical Predictors of Response to Clozapine Treatment in Ambulatory Patients With Schizophrenia PDF quantity
$ 40.00
×
Long-Term, Open-Label Study of the Safety and Efficacy of Atomoxetine in Adults With Attention-Deficit/Hyperactivity Disorder: An Interim Analysis PDF
$ 40.00
Long-Term, Open-Label Study of the Safety and Efficacy of Atomoxetine in Adults With Attention-Deficit/Hyperactivity Disorder: An Interim Analysis PDF quantity
$ 40.00
×
McLean-Harvard International First-Episode Project: Two-Year Stability of ICD-10 Diagnoses in 500 First-Episode Psychotic Disorder Patients PDF
$ 40.00
McLean-Harvard International First-Episode Project: Two-Year Stability of ICD-10 Diagnoses in 500 First-Episode Psychotic Disorder Patients PDF quantity
$ 40.00
×
Efficacy and Safety of Adjunctive Armodafinil in Adults With Major Depressive Episodes Associated With Bipolar I Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial PDF
$ 40.00
Efficacy and Safety of Adjunctive Armodafinil in Adults With Major Depressive Episodes Associated With Bipolar I Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial PDF quantity
$ 40.00
×
Differences in Quality of Life Domains and Psychopathologic and Psychosocial Factors in Psychiatric Patients. PDF
$ 40.00
Differences in Quality of Life Domains and Psychopathologic and Psychosocial Factors in Psychiatric Patients. PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart
